McKesson Corporation (MCK) Highlights Resilience as Its Drug Distribution Network Stands the Test of Time
Eagle Point Capital, an investment firm, has released its “Spring 2026 Portfolio Update” investor letter.. A copy of the book can be download here. The company reported strong quarterly performance while emphasizing its long-term, fundamentals-driven strategy, noting that detailed quarterly returns will be reflected in customer sales statements but reaffirming a stable consolidation consistent with its historical path. The company has attributed its stability to a strong focus on “cockroach-like” businesses, long-lived, core companies that benefit from people’s timeless needs, strong physical infrastructure, and limited vulnerability to rapid technological disruption. Despite the increasingly volatile and unpredictable environment created by global conflicts, inflationary shocks, and rapid changes in technology such as AI, Eagle Point expressed a positive market outlook, arguing that uncertainty and periodic downturns create opportunities for long-term investors. The company believes that its emphasis on strong industries, diverse customer bases, and core services positions the portfolio to withstand disruption and continue to converge over time, as markets face ongoing volatility and structural change. In addition, you can look at the top five funds of the Fund to find out what is the best option for 2026.
In its 2026 Q1 investor note, Eagle Point Capital highlighted stocks like McKesson Corporation (NYSE:MCK). McKesson Corporation (NYSE:MCK) is a healthcare services company that distributes pharmaceuticals and medical products while providing technology solutions to healthcare providers. McKesson (NYSE:MCK)’s one-month return was -11.46% while its shares traded between $637.00 and $999.00 over the past 52 weeks. On May 15, 2026, McKesson (NYSE:MCK) stock closed at approximately $760.57 per share, with a market capitalization of approximately $91.4 billion.
Eagle Point Capital said the following about McKesson Corporation (NYSE:MCK) in its Q1 2026 investor note:
“McKesson Corporation (NYSE:MCK), the oldest company in our portfolio, is a great example. McKesson first delivered medicine by horse and buggy in 1833, almost 200 years ago. The world has changed a lot since then, but what hasn’t been the need to get medicine from point A to point B safely, securely, and efficiently. That is a societal need that will never change.
Today McKesson uses trucks and vans, but one day it may use drones or something else entirely. The world is bound to change in ways we cannot fathom. Those changes will definitely have a trickle-down effect on McKesson. We’re sure McKesson would resist the change for a few reasons (Click here to learn more).
McKesson Corporation (NYSE:MCK) is not on our list of 40 Most Popular Stocks Among Hedge Funds Entering 2026. According to our database, 72 hedge fund portfolios held McKesson Corporation (NYSE:MCK) at the end of the fourth quarter, up from 73 for the previous quarter. While we acknowledge the risk and potential of McKesson Corporation (NYSE:MCK) as an investment, our conviction is based on the belief that other AI stocks hold great promise to deliver high returns and do so over a short period of time. If you’re looking for an extremely overlooked AI stock that will benefit greatly from the Trump-era costs and sea trend, check out our free report best short term AI stock.
In another topicwe’ve rounded up McKesson Corporation (NYSE:MCK) and shared a list of the best cash stocks. In addition, please check our Hedge fund investor letters Q1 2026 page of many investor books from hedge funds and other leading investors.
READ THE FOLLOWING: 33 shares to double in 3 years again 15 Stocks That Will Make You Rich in 10 Years
Disclosure: None. This article was originally published on The inner monkey.
